Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion protein
- 1 January 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 11 (1), 132-141
- https://doi.org/10.1111/jth.12076
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patientsBlood, 2012
- Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogsBlood, 2012
- Purification and characterization of a new recombinant factor VIII (N8)Haemophilia, 2010
- Defining ‘full‐length’ recombinant factor VIII: a comparative structural analysisHaemophilia, 2006
- Genetic diagnosis of haemophilia and other inherited bleeding disordersHaemophilia, 2006
- Structural and functional characterization of B-domain deleted recombinant factor VIIISeminars in Hematology, 2001
- Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.JCI Insight, 1997
- Targeted disruption of the mouse factor VIII gene produces a model of haemophilia ANature Genetics, 1995
- A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.Proceedings of the National Academy of Sciences of the United States of America, 1986
- Structure of human factor VIIINature, 1984